Non-protein stabilized clostridial toxin pharmaceutical compositions

Details for Australian Patent Application No. 2006299366 (hide)

Owner Allergan, Inc.

Inventors Hunt, Terrence J.

Agent Davies Collison Cave

Pub. Number AU-B-2006299366

PCT Pub. Number WO2007/041664

Priority 60/725,126 06.10.05 US; 11/524,683 21.09.06 US

Filing date 4 October 2006

Wipo publication date 12 April 2007

Acceptance publication date 12 January 2012

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2007/041664 Priority application(s): WO2007/041664

12 January 2012 Application Accepted

  Published as AU-B-2006299366

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299372-Two line gas spectroscopy calibration

2006299362-Method and apparatus for randomized printing and bidirectional shifting